123 related articles for article (PubMed ID: 8092117)
1. Neuron-specific enolase as a tumor marker in metastatic melanoma.
Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
Am J Clin Oncol; 1994 Oct; 17(5):430-1. PubMed ID: 8092117
[TBL] [Abstract][Full Text] [Related]
2. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.
Wibe E; Hannisdal E; Paus E; Aamdal S
Eur J Cancer; 1992; 28A(10):1692-5. PubMed ID: 1389487
[TBL] [Abstract][Full Text] [Related]
3. Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
Wibe E; Paus E; Aamdal S
Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416
[TBL] [Abstract][Full Text] [Related]
4. S-100 and NSE as serum markers in melanoma.
Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
[TBL] [Abstract][Full Text] [Related]
5. [Neuron-specific enolase: a serum marker of clinical progression for metastatic malignant melanoma].
Guo HB; Stoffel-Wagner B; Brennemann W; Springer W; Klingmüller D
J Tongji Med Univ; 1995; 15(1):19-25. PubMed ID: 7783258
[No Abstract] [Full Text] [Related]
6. Clinical significance of serum S100 in metastatic malignant melanoma.
Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
Eur J Cancer; 1995 Oct; 31A(11):1898-902. PubMed ID: 8541129
[TBL] [Abstract][Full Text] [Related]
7. Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?
Gross AJ; Michl UH; Bornhöft G; Dieckmann KP
Eur Urol; 1993; 24(3):397-9. PubMed ID: 8262110
[TBL] [Abstract][Full Text] [Related]
8. Neuron-specific enolase--a serum tumour marker in seminoma?
Fosså SD; Klepp O; Paus E
Br J Cancer; 1992 Feb; 65(2):297-9. PubMed ID: 1739633
[TBL] [Abstract][Full Text] [Related]
9. [Neuron-specific enolase and beta 2-microglobulin in the serum of patients with melanoma].
Uerlich M; Biltz H; Kreysel HW
Immun Infekt; 1988 Apr; 16(2):65-7. PubMed ID: 3292403
[TBL] [Abstract][Full Text] [Related]
10. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
Isgrò MA; Bottoni P; Scatena R
Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
[TBL] [Abstract][Full Text] [Related]
11. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
[TBL] [Abstract][Full Text] [Related]
12. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
Harding M; McAllister J; Hulks G; Vernon D; Monie R; Paul J; Kaye SB
Br J Cancer; 1990 Apr; 61(4):605-7. PubMed ID: 2158809
[TBL] [Abstract][Full Text] [Related]
13. [Neuron-specific enolase (NSE)--a suitable tumor marker in malignant melanoma?].
Hornef S; Lux J; Rassner G
Hautarzt; 1992 Feb; 43(2):77-80. PubMed ID: 1347764
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy.
Kamiya N; Akakura K; Suzuki H; Isshiki S; Komiya A; Ueda T; Ito H
Eur Urol; 2003 Sep; 44(3):309-14; discussion 314. PubMed ID: 12932928
[TBL] [Abstract][Full Text] [Related]
15. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
[TBL] [Abstract][Full Text] [Related]
16. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
[TBL] [Abstract][Full Text] [Related]
17. Neuron-specific enolase as a follow-up marker in small cell bronchial carcinoma. A prospective study in an unselected series.
Nõu E; Steinholtz L; Bergh J; Nilsson K; Påhlman S
Cancer; 1990 Mar; 65(6):1380-5. PubMed ID: 2155053
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A and neurone-specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer.
Fan L; Wang Y; Chi C; Pan J; Xun S; Xin Z; Hu J; Zhou L; Dong B; Xue W
BJU Int; 2017 Aug; 120(2):226-232. PubMed ID: 28107595
[TBL] [Abstract][Full Text] [Related]
19. Neuron-specific enolase as serum marker for malignant melanoma.
Couvreur R; Joos G; Geerts ML; Lambert J; Naeyaert JM
Lancet; 1993 Oct; 342(8877):985. PubMed ID: 8105228
[No Abstract] [Full Text] [Related]
20. Correlation between lipid-associated sialic acid and tumor burden in melanoma.
Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
Int J Biol Markers; 1994; 9(4):247-50. PubMed ID: 7836804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
